Cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and cytochrome P450 (CYP) 4A-mediated arachidonic acid (AA) metabolism play an essential role in human inflammatory disorders. Blocking COX-2 pathway would shunt AA metabolism to the other pathway, thereby decreasing the efficacy and exacerbating adverse effects. Here we demonstrated that reprogramming COX-2, 5-LOX, and CYP4A-mediated AA metabolism in macrophages by salidroside (Sal) ameliorates monosodium urate (MSU) crystal-induced inflammation. Compared with COX-2 inhibitor celecoxib, Sal (80 mg/kg) presented a superior anti-arthritic profile in MSU crystal-treated rats, accompanied with the decreased expression of COX-2, 5-LOX, and CYP4A and production of prostaglandin E2 (PGE 2 ), leukotriene B4 (LTB 4 ), and 20-hydroxyeicosatetraenoic acid in the synovial fluid macrophages. Sal decreased representative M1 marker (iNOS and CD86, etc.) expression and M1 cytokine (TNF-and IL-1 ) production, whereas it increased M2 marker (CD206 and Arg-1) expression and M2 cytokine (TGF-and IL-10) production. The injection of conditioned medium from MSU crystal-treated macrophages into the ankle joint of rats reproduced the gouty inflammation, which was attenuated by Sal. Mechanistically, down-regulation of COX-2, 5-LOX, and CYP4A in the RAW264.7 and NR8383 macrophages by Sal skewed macrophage polarization away from the M1 phenotype, and thereby prevented neutrophil migration and chondrocyte degradation with STAT1 and NF-B inactivation. Conversely, overexpression of COX-2, 5-LOX, CYP4A or STAT1, or exogenous addition of IL-1 or TNF-partially abolished these effects. Together, inhibition of COX-2, 5-LOX, and CYP4A in macrophages by Sal ameliorates MSU crystal-induced inflammation through decreasing TNF-and IL-1 production, and may serve as a novel therapeutic strategy.
extremes of the phenotypic spectrum of macrophages are defined as the classically activated M1-like phenotype and the alternatively activated M2-like phenotype. 6 Polarization of macrophages toward M1 phenotype promotes proinflammatory cytokine IL-1 and TNF-production, and exacerbates a gout attack in response to MSU crystals. 7 Therefore, inhibition of macrophage M1 polarization to decrease IL-1 and TNF-production could represent a promising strategy for gouty arthritis therapy.
Cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) 4A mainly metabolized arachidonic acid (AA) to prostaglandin E 2 (PGE 2 ), leukotriene B 4 (LTB 4 ), and 20-hydroxyeicosatetraenoic acid (20-HETE), respectively. 8 These eicosanoids are key proinflammatory mediators of the inflammatory cascade. 9,10 PGE 2 and LTB 4 contribute to IL-1 production, and are thought to be important mediators in gout attack. [11] [12] [13] Cyclooxygenase-2 (COX-2) inhibitors have been used clinically to treat gouty arthritis. 2 Additionally, knockout of 5-lipoxygenase (5-LOX) or blockade of LTB 4 production down-regulates IL-1 and thus decreases functional joint impairment in a murine model of gout. 11 When inhibiting the COX pathway by indomethacin, AA metabolism will mainly switch to the 5-LOX/LTB 4 pathway rather than other cascades including 15-LOX pathway. 14 The COX-2 inhibitor rofecoxib also shunts AA metabolism toward the CYP4A/20-HETE pathway, and its combination with the CYP4A inhibitor HET0016 enhances antitumor efficacy with the reduced cerebrovascular side effects. 15 Therefore, multi-enzyme inhibitors that target COX-2, 5-LOX, and CYP4A may have advantage in alleviating gouty inflammation. However, the role of CYP4A-mediated AA metabolism in MSU crystal-induced inflammation has not been investigated.
Salidroside (Sal, p-hydroxyphenethyl--D-glucoside, structure shown in Supplemental Fig. 1 ), one of the main active substances from Rhodiola rosea L., possesses anti-inflammatory effects. 16 Sal inhibits COX-2 protein expression and TNF-and IL-1 production in lipopolysaccharide-treated RAW264.7 macrophages, 17 and downregulates protein expression of COX-2 and 5-LOX in ethanol-induced gastric ulcer and H 2 O 2 -induced gastric epithelial cell damage. 18 In addition, Sal alleviates collagen-induced rheumatoid arthritis, though its mechanism of action has not been elucidated. 19 In the present study, we demonstrated that inhibition of COX-2, 5-LOX, and CYP4A-mediated AA metabolism in macrophages by Sal ameliorates MSU crystal-induced gouty arthritis through decreasing production of macrophage-derived TNF-and IL-1 . Our results could lead to a potential novel therapeutic strategy for gouty arthritis.
MATERIALS AND METHODS

Materials
Sal with high purity (>98%) was obtained from the National Institutes for Food and Drug Control (Beijing, China). MSU crystals and zoledronic acid (ZA) were purchased from Sigma Chemical Co. (St.
Louis, MO, USA). Clodronate (Clod) was purchased from Roche Diagnostics (Indianapolis, IN, USA). Rat recombinant IL-1 and TNFwere purchased from Pepro Tech (Rocky Hill, NJ, USA). Antibodies against CD68, COX-2, 5-LOX, CYP4A, E-prostanoid receptor 2 (EP2), leukotriene B4 receptor 1 (BLT1), a disintegrin and metalloproteinase with thrombospondin motif (ADAMTS-5), signal transducers and activators of transcription (STAT) 1, p-STAT1, I B, p-I B, p-p65, and p65 were purchased from Abcam (Cambridge, MA, USA). Antibodies against F4/80, iNOS and MMP-13 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). ELISA for mouse or rat TNF-, IL-1 , TGF-, and IL-10 were purchased from R&D Systems (Minneapolis, MN, USA). ELISA kits for PGE 2 and LTB 4 were purchased from Cayman Chemical Co. (Ann Arbor, MI, USA). Other reagents were of analytic grade from commercial suppliers and manufactured in China.
Cell culture
Mouse macrophage cell line RAW264.7 and rat macrophage cell line NR8383 were obtained from the American Type Culture Collection (Manassas, VA, USA). The cells were grown in DMEM containing 10% FBS in a humidified atmosphere of 5% CO 2 at 37 • C. Primary mouse articular chondrocytes were isolated as previously described. 20 All culture reagents contained less than 0.125 endotoxin unit/ml as checked by Limulus amebocyte lysate assay (BioWhittaker [Walkersville,
MD, USA]).
Mouse neutrophils were isolated from peripheral blood as previously described, 21 and more than 95% of them were morphologically mature neutrophils.
Animal experiments
Male Wistar rats (200-250 g) and male New Zealand rabbits (1.6-2.2 kg) were purchased from Centers for Disease Control and Prevention (Hubei, China). The animals were acclimatized 1 week to adapt to new environment before the experiment. All animals were fed standard chow diet and tap water ad libitum, and housed at room temperature (18- A rat model of MSU crystal-induced gouty arthritis was established as previously described. 22 As shown in Figure 1A , after rats were anesthetized, 50 l of MSU crystals (20 mg/ml) or normal saline was injected into the medial side of the right tibio-tarsal joint 
Histologic examination and immunohistochemistry
The rat ankle joints from MSU alone, MSU plus Sal (40 and 80 mg/kg), MSU plus celecoxib (60 mg/kg), or vehicle-treated groups were fixed in 4% paraformaldehyde, decalcified in 10% EDTA, embedded in paraffin, sectioned, and stained with H&E. Histologic changes were graded on a 0-3 scale, 26 where 0 = no cellular infiltration, 1 = thicker-appearing synovial membrane and inflammatory cell infiltration, 2 = further thickening of the synovial membrane and moderate increase in inflammatory cells, and 3 = dramatic increase in inflammatory cells and synovial membrane forming pannus. Scoring was performed by 2 investigators who were blinded to experimental groups.
For the immunohistochemistry staining of F4/80 and p65, the synovial tissue sections were incubated with antibody against rat F4/80
(1:100) or p65 (1:200) in a humidified chamber overnight at 4 • C, followed by incubation with HRP-conjugated secondary antibody at 37 • C for 1 h and reacted with 3, 3 ′ -diaminobenzidine tetrahydrochloride (DAB). All slides were analyzed using an upright microscope (Olympus BX51, Tokyo, Japan) in combination with a digital image output system. The numbers of positive cells (at least 5 fields per section) were recorded. Every fifth section was used for stereological assessment.
Immunofluorescence
The synovial tissue sections from rats treated with MSU alone, MSU plus Sal (40 and 80 mg/kg) or vehicle were labeled with anti-CD68 (1:100) and anti-iNOS (1:100) or anti-CYP4A (1:50) antibodies overnight at 4 • C for co-localization detection. After washing, the sections were incubated with a mixture of Alexa Fluor 488-and Alexa Fluor 594-conjugated secondary antibodies for 1 h. Nuclei were counterstained with DAPI.
Isolation of macrophages
Macrophages were isolated from the synovial fluid employing a negative selection kit (StemCell Technologies, Vancouver, Canada) according to the manufacturers' instructions. 27 The cells were analyzed by flow cytometry for macrophage markers (F4/80 and CD68) to ensure purity of macrophage isolation. The purity of the synovial fluid macrophages was >95%. Freshly isolated synovial fluid macrophages were incubated in 12-well plates at 80% to 90% confluence, washed with PBS, and resupplied with serum-free media for 24 h. The supernatants were collected, centrifuged to remove cellular debris, and then frozen at −80 • C until assessed. 
Flow cytometry
Immunofluorescence cytochemistry
RAW264.7 macrophages were fixed in 4% paraformaldehyde for 24 h and then permeabilized with 0.1% Triton X-100 for 10 min. After rinsing, the cells were blocked with 10% goat serum for 30 min and incubated with antibody against mouse p65 (1:100) overnight at 4 • C. After washing, the cells were incubated with Alexa Fluor 594-coujugated secondary antibody for 1 h and then counterstained with DAPI.
Lentiviral transduction
RAW264.7 macrophages were seeded at a density of 2 × 10 5 into a 6-well culture plate in 3 ml of DMEM supplemented with 10% FBS per well. When grown to 80% confluence, cells were infected with lentiviral activation particles for COX-2, 5-LOX, CYP4A10, or STAT1 (Santa Cruz Biotechnology) for 24 h. The cells treated with negative control lentivirus (LV-NC) were as the control. COX-2, 5-LOX, CYP4A, and STAT1 expression was measured by Western blot.
CM preparation
CM was prepared as previously described with a minor modification. 28 Briefly, NR8383 or RAW264.7 macrophages at 1 × 10 6 /well in 6-well plates stimulated with or without MSU (500 g/ml) were treated with Sal (150 and 300 M) or vehicle for 24 h. The culture supernatants were harvested, and then subjected to centrifugation through an Amicon Ultra-4 filter to remove any traces of Sal. The retentate was collected as CM.
Chondrocyte viability test
Primary rat articular chondrocytes at 1 × 10 4 /well in 96-well plates were treated with the CM as described above for 24 h. Cell viability was measured according to the protocol of 3-(4, 5-dimethylthiazol-
Migration assay
A migration assay was performed as previously described with a minor modification. 29 Briefly, the CM from RAW264.7 cells treated with MSU (500 g/ml) with or without Sal for 24 h was added to the lower chamber. The neutrophils (5 × 10 5 ) were added to the upper chamber.
The cells were incubated for 1 h to migrate across the 8 m transwell insert (Corning, NY, USA) toward the lower chamber. The cells that did not migrate and remained in the upper chamber were removed. The cells that migrated to the lower chamber were counted.
Quantitative real-time PCR assay
Total RNA was isolated with Trizol (Invitrogen, Carslbad, CA, USA) according to the manufacturer's instruction. RNA concentration and purity were estimated with a spectrophotometer at 260 and 280 nm, respectively. RNA was reverse transcribed to cDNA by a PrimeScript TM RT reagent Kit with gDNA Eraser (Takara, Dalian, China). cDNA templates (2 l) were amplified in a final volume of 25 l containing the SYBR Green PCR Master mix (Takara) and primer.
Melting-curve analysis was used to confirm amplicon specificity. Relative amount of transcripts was calculated using the 2 −ΔΔCt formula.
-actin served as the reference gene. 30 The sequences of primers used in the present study were given in Supplemental Table 1 .
Western blot assay
Proteins in the synovial fluid macrophages, RAW264.7 and NR8383 macrophages were extracted. Based on the concentration determined by Bradford method, equal amounts of protein extracts were subjected to electrophoresis in SDS-polyacrylamide gels and transferred to polyvinylidene fluoride (PVDF) membranes. The membranes were then blocked with 5% nonfat milk for 2 h at room temperature and cultured overnight at 4 • C with the primary antibodies against COX-2, 5-LOX, CYP4A, EP2, BLT1, MMP13, ADAMTS-5, STAT1, p-STAT1, I B , p-I B , p-p65, or -actin. The blots were washed, incubated with peroxidase-conjugated anti-rabbit and anti-mouse immunoglobulin G (CST) and detected using the ECL system (Thermo Fisher Scientific, Waltham, MA, USA). Band intensity was quantified by densitometric analysis using the NIH ImageJ Program (http://rsb.info.nih.gov/ij/). The relative expression was normalized to the expression of -actin. 
Cytokine measurement
20-HETE measurement
20-HETE was analyzed by liquid chromatographic-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) as previously described. 31 The samples (200 l) were spiked with 2 ng of d8-20- 
Molecular docking study
The crystal structure of human COX-2 (PDB id: 5IKT) was retrieved from the protein data bank (PDB). The homology model of human 5-LOX and human CYP4A11 was automatically generated by the SWISS-MODEL program using the crystal structure of human mutant 5-LOX (PDB id: 3V99) and oryctolagus cuniculus CYP4B1 (PDB id: 5T6Q) as a template. The molecular docking study was performed using the Surflex-Dock of SYBYL-X 2.0 (Tripos, St. Louis, MO, USA).
The SYBYL software was used to assign the standard AMBER atomic partial charges on the COX-2, 5-LOX, and CYP4A11 protein and the Gasteiger-Hückel atomic partial charges on the ligand molecule (Sal) to be docked. After the preparation, the docking was performed using the default settings, and the figures were generated using PyMol (http://www.pymol.org).
Statistical analysis
All values were expressed as mean ± SEM. Statistical analyses were performed using a one-way ANOVA followed by the Student-NewmanKeul's test for multiple group comparisons. Statistical significance 
RESULTS
Sal ameliorates MSU crystal-induced gouty arthritis in rats and rabbits
We first measured the circumference of the injected ankle joints in a rat model of gouty arthritis. As shown in Figure 1B , ankle swelling rate was significantly higher in the MSU group than in the control group. Conversely, Sal (40 and 80 mg/kg) or COX-2 inhibitor celecoxib decreased ankle swelling rate. Importantly, Sal (80 mg/kg) decreased ankle swelling rate over celecoxib at 16 h. We then assessed gait alteration, and observed over-flexion of the right hind limb at 9 h after MSU crystal injection, reaching the peak at 24 h. In contrast, Sal (80 mg/kg) decreased gait score as compared with the MSU or celecoxib group (Fig. 1C) . Next, leukocytes in the synovial fluid were measured. As expected, significantly decreased leukocyte number in the synovial fluid was observed in the Sal or celecoxib-treated group compared to the MSU group, suggesting that these agents prevent leukocyte recruitment into joints (Fig. 1D) . Neutrophil influx into the joint fluid is a hallmark of gouty arthritis. 32 We found that the number of neutrophils in the synovial fluid was significantly decreased in the Sal (80 mg/kg)-treated group as compared with the MSU or celecoxib group (Fig. 1D) . In addition, synovial membrane in the MSU group showed obvious leukocyte infiltration, hemorrhagic areas and hyperplasia, which was decreased by Sal or celecoxib (Fig. 1E and F) . The body weight and food intake of all rats were monitored throughout the study. As shown in Figure 1G , the body weight and food intake at day 6 were significantly decreased in the MSU group as compared (Fig. 1H-K) . These data suggest that Sal exhibits superior therapeutic effects on MSU crystal-induced gouty arthritis with little side effects compared to the celecoxib. 10, 33 We found that MSU crystals increased PGE 2 , LTB 4 , and 20-HETE production in the synovial fluid macrophages (Fig. 2A) .
Sal alters COX
Celecoxib decreased PGE 2 production by 66% but increased LTB 4 and 20-HETE secretion by 73.6% and 48.4%, respectively ( Fig. 2A) , similar to previous studies. 14, 15 Conversely, Sal (40 and 80 mg/kg) significantly decreased PGE 2 , LTB 4 , and 20-HETE production ( Fig. 2A) . Treatment with Sal (40 mg/kg) tended to inhibit the mRNA expression of COX-2, 5-LOX, and CYP4A though the difference did not reach significance. Of note, Sal at the dose of 80 mg/kg significantly inhibited COX-2, 5-LOX, and CYP4A mRNA expression, without affecting the COX-1 mRNA expression (Fig. 2B) . COX-2 and 5-LOX-mediated AA metabolism is up-regulated in macrophages in gouty inflammation. 11, 34 The coexpression of CYP4A with CD68 + macrophages in synovial tissues showed that CYP4A expression in macrophages was increased in the MSU group but decreased in the Sal-treated groups (Fig. 2C) . Next, by molecular docking we investigated whether Sal binds to the catalytic sites of 5-LOX and CYP4A in addition to COX-2. Similar to previous study, 16 Sal interacted with MET522, VAL523, and SER530 of COX-2 through a hydrogen bond (H-bond) and formed several hydrophobic interactions with key catalytic site residues such as ARG120, TYR355, TYR385, and TRP387 of COX-2 (Fig. 2D) . When docked into the homology model of 5-LOX, Sal formed H-bond with TYR181, GLN363, HIS600, and ILE673 of 5-LOX and interacted with THR364 through a lipophilic interaction (Fig. 2E) . In addition, Sal formed H-bond interactions with LEU494, ASP-324, and GLU321 of CYP4A (Fig. 2F) . These data suggest that Sal reprograms COX-2, 5-LOX, and CYP4A-mediated AA metabolism in MSU crystal-treated synovial fluid macrophages.
Sal polarizes macrophages away from the M1 phenotype
To examine if Sal modulates macrophage phenotype switch, we determined macrophage polarization status in the rat model of gouty arthritis. M1-like macrophages are characterized by high expression of iNOS, CD86, TNF-, and IL-1 , and M2-like macrophages are characterized by high expression of CD206 and Arg-1. 35, 36 As shown in Figure 3A and B, MSU crystals increased the number of CD68 + iNOS + (M1) macrophages, whereas Sal decreased M1 macrophages without affecting the number of CD68 + macrophages. We then measured The values are presented as the mean ± SEM, n = 7. * P < 0.05, ** P < 0.01 vs. control, # P < 0.05, ## P < 0.01 vs. MSU M1 and M2 signature genes by qPCR. As shown in Figure 3C , MSU crystals increased M1 genes (TNF-, iNOS, IL-1 , and CD86) but not altered M2 genes (CD206 and Arg-1). In contrast, Sal decreased M1 genes but increased M2 genes. We finally assayed the function of polarized macrophages, and found that Sal significantly decreased production of M1 cytokines (TNF-and IL-1 ), and increased production of M2 cytokines (TGF-and IL-10) (Fig. 3D) . These data suggest that macrophages in the inflamed joints were predominantly of the M1-like phenotype, whereas Sal polarizes macrophages away from the M1 phenotype.
Next, we investigated whether down-regulation of COX-2, 5-LOX, and CYP4A by Sal inhibits macrophage M1 polarization in vitro. As shown in Figure 4A , the percentage of CD86 + cells was increased in the MSU group as compared with the control, and these effects were attenuated by Sal. In addition, MSU crystals increased M1 genes (iNOS and CD86). In contrast, Sal (150 and 300 M) down-regulated M1 genes ( Fig. 4B and C) , without affecting the proliferation of RAW264.7 and NR8383 macrophages (Supplemental Fig. 2A and B) . In line with the above data, Sal inhibited M1 cytokine (TNF-and IL-1 ) production (Fig. 4D) . Furthermore, Sal (300 M) decreased production of PGE 2 , LTB 4 , and 20-HETE and protein expression of EP2 and BLT1 in MSU crystal-treated RAW264.7 and NR8383 macrophages (Fig. 4E-G ). The decrease in the iNOS and IL-1 in the Sal (300 M)-treated group was more significant than in the celecoxib-treated group, and overexpression of COX-2, 5-LOX, or CYP4A attenuated Sal (300 M)-mediated decrease in the iNOS and IL-1 ( Fig. 4H and I Fig. 3B and C) . These data suggest that Sal inhibits COX-2 and 5-LOX via AMPK activation.
Inhibition of COX-2, 5-LOX, and CYP4A by Sal alleviates M1 macrophage-mediated gouty arthritis
To clarify whether macrophages participate in gouty arthritis, and . Each value presents the mean ± SEM of 3 independent triplicate experiments. * P < 0.05, ** P < 0.01 vs. control, # P < 0.05, ## P < 0.01 vs. MSU,^P < 0.05 vs. Sal (Fig. 5A-C) . Elimination of macrophages from MSU crystal-treated rats significantly decreased ankle swelling rate, walking gait score and histologic score (Fig. 5D-F) , indicating that macrophages were predominantly of the M1-like, proinflammatory phenotype during gouty arthritis. When macrophages were depleted, no changes in the ankle swelling rate, gait score, and histologic score were observed in Sal-treated rats (Sal+Clod/ZA) and vehicle-treated rats (Clod/ZA) ( Fig. 5D-F) .
To support the results obtained in the in vivo depletion experiments, the CM from NR8383 macrophages treated with vehicle, MSU, or MSU plus Sal was injected into the medial side of the right tibiotarsal joint of rats. As shown in Fig. 6A -C, the CM from MSU-treated macrophages increased ankle swelling rate, walking gait score, neutrophil recruitment, and histologic score, whereas inhibition of COX-2, 5-LOX, and CYP4A by Sal attenuated these effects. Interestingly, co-injection of the Sal-CM with IL-1 and TNF-reproduced the effects on ankle swelling rate and neutrophil recruitment induced by the MSU-CM (Fig. 6D) . These data suggest that COX-2, 5-LOX, and CYP4A inhibition by Sal alleviates M1 macrophage-mediated gouty arthritis.
Inhibition of COX-2, 5-LOX, and CYP4A by Sal prevents neutrophil migration and chondrocyte degradation through down-regulation of macrophage-derived IL-1 and TNF-
Neutrophil influx into the joints and cartilage damage are important features of gouty arthritis. 32,38 Therefore, we investigated whether M1 macrophage-derived IL-1 and TNF-could have a significant impact on in vitro neutrophil migration and chondrocyte degradation. As expected, treatment with the MSU-CM significantly increased neutrophil migration, which was inhibited by Sal (Fig. 6E) . Moreover, MSU-CM decreased chondrocyte viability and mRNA expression of aggrecan and type II collagen (cartilage markers), whereas Sal attenuated these effects (Fig. 6F and G) . ADAMTs and MMP-13 play essential roles in the degradation of type II collagen and aggrecan in cartilage. 39 We found that Sal inhibited ADAMTS-5 and MMP-13 (catabolic markers) mRNA and protein expression induced by the MSU-CM (Fig. 6H and I). Furthermore, the effects of Sal on neutrophil migration, chondrocyte viability, and ADAMTS-5 and MMP-13 mRNA expression were partially reversed by overexpression of COX-2, 5-LOX, CYP4A, or F I G U R E 5 Macrophage depletion alleviates gouty arthritis in a rat model of gouty arthritis. Rats were intra-articularly injected with MSU crystals (20 mg/ml). The clodronate (Clod) (100 mg/kg) liposomes were administrated intraperitoneally 1 h after MSU crystals were injected into the medial side of the right tibio-tarsal joint of each rat. In another experiment, the zoledronic acid (ZA) (100 g/kg) liposomes were injected intravenously. Sal (80 mg/kg) was intragastrically administered once daily for 6 (Fig. 6J) . These data suggest that COX-2, 5-LOX, and CYP4A inhibition by Sal prevents neutrophil migration and chondrocyte degradation through inhibiting M1 macrophagederived factors, especially including IL-1 and TNF-.
STAT1 and NF-B signaling are involved in down-regulation of macrophage-derived IL-1 and TNF-by Sal
STAT1 or NF-B is crucial for M1 macrophage polarization. 40 We observed the increased p-STAT1, p-I B , and p-p65 in the synovial fluid macrophages from MSU crystal-treated rats, which were attenuated by Sal (Fig. 7A-C) . Consistently, we demonstrated the increased p-STAT1 and p-I B level, as well as the p65 nuclear translocation in MSU crystal-treated RAW264.7 macrophages (Fig. 7D-G) . In contrast, Sal decreased p-STAT1, p-I B and p65 nuclear translocation, which were partially reversed by COX-2 or 5-LOX overexpression (Fig. 7D-G) .
Interestingly, CYP4A overexpression increased p65 nuclear translocation, but did not affect p-STAT1 (Fig. 7E-G) . Moreover, STAT1 overexpression partially reversed the decreased iNOS mRNA expression and M1 factor (IL-1 and TNF-) production induced by Sal (Fig. 7H and   I ). These results suggest that COX-2, 5-LOX, and CYP4A inhibition in macrophages by Sal down-regulates IL-1 and TNF-via STAT1 and NF-B signaling.
DISCUSSION
In the present study, 2 novel observations have been made. First, we found that inhibition of COX-2, 5-LOX, and CYP4A in macrophages by Sal exhibits superior therapeutic effects on MSU crystal-induced gouty arthritis with little side effects compared to the COX-2 inhibitor celecoxib. To our knowledge, this is the first study that directly demon- One explanation for this may be that inhibition of COX pathway would shunt AA metabolism to 5-LOX and CYP4A pathways, thereby decreasing the efficacy and exacerbating adverse effects. 15, 42 Inhibition of both COX pathway and 5-LOX or CYP450 pathway elicits an additive therapeutic efficacy and improved safety profile compared with pure COX blockers. 15, 43 Here, we demonstrated that COX-2, 5-LOX, and CYP4A-mediated AA metabolism was upregulated in synovial fluid macrophages and MSU crystal-induced RAW264.7 and NR8383 macrophages. The COX-2 inhibitor celecoxib shunted AA metabolism to the 5-LOX and CYP4A pathways.
Conversely, COX-2, 5-LOX, and CYP4A inhibition by Sal exhibits superior therapeutic effects on MSU crystal-induced gouty arthritis compared to the COX-2 inhibitor celecoxib, evidenced by a decrease in ankle swelling rate at 16 h, gait score and the number of neutrophils in the synovial fluid. Previous study showed that Sal is low-toxic and has cardioprotective and gastroprotective effects. 18, 44 We demonstrated that the rats treated with Sal (40 and 80 mg/kg) tended to maintain body weight and food intake better than celecoxib-treated rats, though the difference did not reach significance. These data suggest that inhibition of COX-2, 5-LOX, and CYP4A by Sal could provide more effective and safe way against gouty arthritis. After intragastric administration of Sal (40 mg/kg) to the rats, the peak plasma concentration (C max ) was 37 M. 19 We found that Sal at the concentration of 150 The values are presented as the mean ± SEM. * P < 0.05, ** P < 0.01 vs. control, # P < 0.05, ## P < 0.01 vs. MSU,^P < 0.05,^^P < 0.01 vs. Sal or Lv-NC and 300 M (about 4-and 8-fold of C max , respectively) decreased in vitro production of PGE 2 , LTB 4 , and 20-HETE. Recent studies showed that the Rhodiola rosea alters the gut microbial community of fly, 45 and gut microbiota represents new elements that influence the pathogenesis of gouty arthritis. 46 Therefore, further experiments are being carried out to investigate whether gut microbiome is involved in the antiarthritic effect of Sal.
Macrophages, one of the most abundant cells in the inflamed joints, regulate secretion of proinflammatory cytokines and enzymes. 47 Polarization of macrophages toward the proinflammatory M1 phenotype exacerbates a gout attack. 7 Here, we demonstrated that Sal skewed macrophage polarization away from the M1-like phenotype in MSU crystal-induced inflammation. Recent studies show that M1-like macrophages and their cytokines promote progression of multiple tumors. 48, 49 These data suggest that Sal polarizes macrophages far from the M1 phenotype and thus exerts anti-arthritic and antitumor effects. IL-1 is pivotal for MSU crystal-induced gouty arthritis, and there is sufficient evidence supporting the use of IL-1 blockers for treatment of gouty arthritis. 50 Although arguing against a leading role for TNF-in gouty arthritis, there are reports of refractory gout patients responding to anti-TNF therapy. 51 Here we demonstrated that blockade of COX-2, 5-LOX, and CYP4A by Sal decreased both IL-1 and TNF-production in the synovial fluid macrophages and MSU crystal-treated RAW264.7 and NR8383 macrophage. Thus, down-regulation of macrophage-derived IL-1 and TNF-by reprogramming COX-2, 5-LOX, and CYP4A-mediated AA metabolism could be a novel strategy for gouty arthritis therapy.
NF-B activation is involved in the pathogenesis of human gouty arthritis, 52 and STAT1 is up-regulated in synovial fluid monocytes in patients with rheumatoid arthritis. 53 However, their roles in gout has not been fully elucidated. We demonstrated that inhibition of COX-2, 5-LOX, and CYP4A-mediated AA metabolism by Sal decreased p-STAT1 and p65 nuclear translocation in the synovial fluid macrophages and MSU crystal-induced RAW264.7 macrophages. Conversely, COX-2 and 5-LOX overexpression attenuated Sal-induced decreases in both p-STAT1 and p65 nuclear translocation. These results suggest that both COX-2 and 5-LOX promote MSU crystal-induced macrophage M1 polarization via NF-B and STAT1 pathway. Previous study showed that CYP4A/20-HETE stimulates NF-B activation and the production of inflammatory cytokines in human endothelial cells. 54 We found that CYP4A overexpression partially reversed the effect of Sal on p65 nuclear translocation without significantly affecting p-STAT1, indicating that CYP4A promotes macrophage M1 polarization in MSU crystal-induced inflammation mainly via NF-B but not STAT1. Previous study showed that COX-2/PGE 2 and 5-LOX/LTB 4 , respectively, bind to EP2 and BLT1 and induce ERK pathway, 55 which phosphorylate p65 and STAT1. 56, 57 In addition, COX-2/PGE 2 /EP2, 5-LOX/LTB 4 /BLT1, and CYP4A/20-HETE activate PI3K/Akt pathway, 55, 58 which is an upstream activator of NF-B. 59 Thus, we speculate that inhibition of 
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